Examkin

Question

Difficulty: HardImmunizations and Vaccine-Preventable Diseases

A 67-year-old man comes to the clinic for a pre-travel consultation. He is planning a 3-week trip to rural areas of Ghana and Nigeria. His medical history is notable for hypertension, hyperlipidemia, and a thymectomy performed 10 years ago for a benign thymoma. Current medications include lisinopril and atorvastatin. Vital signs are within normal limits. Physical examination shows a well-healed midline sternotomy scar but is otherwise unremarkable. He has received all routine vaccinations, including an updated tetanus-diphtheria-pertussis (Tdap) vaccine 2 years ago. He asks about the yellow fever vaccine, which is required for entry into his destination countries. Which of the following is the most appropriate next step in management regarding the yellow fever vaccine for this patient?

  1. Provide a medical waiver letter and advise on strict mosquito-avoidance measuresAnswer
  2. B
    Administer the standard dose of the live-attenuated yellow fever vaccine
  3. C
    Administer the inactivated yellow fever vaccine
  4. D
    Check the CD4 T-lymphocyte count before administering the live-attenuated vaccine
  5. E
    Administer the live-attenuated yellow fever vaccine along with prophylactic immune globulin

Answer

Provide a medical waiver letter and advise on strict mosquito-avoidance measures.
The correct action is to provide a medical waiver letter and advise on strict mosquito-avoidance measures. The yellow fever vaccine is a live-attenuated viral vaccine. It is absolutely contraindicated in patients with a history of any thymus disorder, including thymoma, thymectomy, myasthenia gravis, or DiGeorge syndrome. This is because thymus disorders are associated with a dramatically increased risk of developing yellow fever vaccine-associated viscerotropic disease (YEL-AVD). YEL-AVD is a severe, frequently fatal multisystem illness that clinically resembles severe wild-type yellow fever infection. Because this patient is traveling to countries that mandate the vaccine for entry (Ghana and Nigeria), the standard medical protocol for a patient with a true medical contraindication is to provide an official vaccination waiver letter. Furthermore, because he will remain fully susceptible to yellow fever, he must be extensively counseled on strict mosquito bite prevention strategies (e.g., DEET, permethrin-treated clothing, bed nets). Note that his age (>60 years) is also an independent precaution for the vaccine, but the thymectomy acts as a hard contraindication.

Step-by-Step Solution

1
Identify the patient's destination and specific vaccination requirements.
The patient is traveling to Ghana and Nigeria, where yellow fever vaccination is required for entry and the disease is endemic.
Determines the necessity of the vaccine versus the risk of exposure.
2
Evaluate the patient's medical history for contraindications to the yellow fever vaccine.
The patient has a history of a thymectomy for a thymoma, which is an absolute contraindication to the live-attenuated yellow fever vaccine.
Identifying contraindications is critical to prevent severe, life-threatening vaccine adverse events.
3
Determine the alternative management when a required travel vaccine is contraindicated.
The provider should supply a medical waiver letter for travel and counsel heavily on alternative disease prevention (mosquito avoidance).
Allows the patient to meet travel entry requirements while prioritizing their safety from vaccine complications.

Key Concept

A history of a thymus disorder (e.g., thymoma, thymectomy, myasthenia gravis) is an absolute contraindication to the live-attenuated yellow fever vaccine due to an increased risk of severe yellow fever vaccine-associated viscerotropic disease (YEL-AVD).
Estimated Time:1m 30s
Rate this question

Topics

Immunizations and Vaccine-Preventable Diseases

More questions from this topic